For decades, the gold standard in adipose tissue reconstruction has remained lipofilling — the transfer of autologous fat harvested from the patient and reinjected into deficient areas. It is a technique elegant in principle, but laden with practical limitations: the variable and often unpredictable resorption of transplanted tissue, the need for adequate donor sites, and the uncertain survival of adipocytes in the early postoperative phase. These challenges have driven, in recent years, an increasingly intense search for bioactive scaffolds capable of guiding adipose regeneration in a controlled and lasting manner. Among the emerging materials in this field, silk fibroin has carved out a position of absolute prominence.
Why fibroin is so well suited to adipose regeneration
The selection of a biomaterial for reconstructive applications is never arbitrary. It must meet a range of requirements spanning biocompatibility, the ability to mimic the architecture of the native extracellular matrix, and a degradation kinetics compatible with the timelines of tissue regeneration. Fibroin excels across each of these domains, but what makes it particularly suited to adipose reconstruction is its extraordinary structural versatility: it can be processed into hydrogels, porous sponges, films, micro- and nanoparticles, and electrospun fibers. This technological malleability allows scaffolds to be engineered with porosity, mechanical stiffness, and degradation rates tailored to the target tissue. Adipose tissue, unlike bone or cartilage, requires a particularly soft and deformable scaffold, with a mechanical stiffness in the kilopascal range — values that fibroin hydrogels and sponges can achieve and modulate with relative precision by controlling the degree of protein crystallinity. At the same time, interconnected porosity promotes vascularization, an essential condition for the long-term survival of newly formed adipocytes and mesenchymal stem cells seeded within the scaffold.
Bioactive functionalization strategies
A passive scaffold alone is not sufficient to guide adipogenic differentiation efficiently. This is where the concept of "bioactive fibroin" comes into play: a matrix that does not merely provide physical support, but actively instructs cells through biochemical signals embedded within the material's very structure.
The functionalization strategies explored in the literature are numerous. One of the most established involves incorporating adipogenic growth factors — primarily VEGF to promote angiogenesis and bFGF to stimulate cell proliferation — directly into the fibroin matrix, exploiting the protein's capacity to bind and slowly release bioactive molecules in a manner dependent on enzymatic degradation. This sustained release avoids the concentration spikes typical of conventional local administration, while simultaneously reducing the total amount of factor required.
A second strategy, more recent and conceptually refined, consists of directly conjugating bioactive peptides derived from the native extracellular matrix of adipose tissue — fragments of fibronectin, laminin, or collagen IV — onto the fibroin protein chain. These act as anchoring and differentiation signals for adipocyte precursor cells and adipose-derived stem cells (ASCs). Such approaches have demonstrated a significant acceleration of lipogenesis in vitro and, in certain animal models, improved volumetric retention compared to non-functionalized scaffolds.
A third line of research, still predominantly exploratory, involves the use of fibroin scaffolds enriched with stem cell-derived exosomes or non-coding RNAs capable of modulating intracellular adipogenic pathways — an approach that projects bioactive fibroin toward the most advanced frontiers of regenerative medicine.
Integration with adipose-derived stem cells
No scaffold, however sophisticated, can regenerate adipose tissue in the absence of an adequate cell source. The current paradigm in reconstructive surgery therefore involves the combined use of bioactive fibroin scaffolds and adipose-derived stem cells, isolated through centrifugation of the stromal vascular fraction of lipoaspirate. ASCs are now recognized as the central protagonists of adipose regeneration, owing to their capacity to differentiate into mature adipocytes, secrete pro-angiogenic factors, and modulate the local inflammatory response in a pro-regenerative direction.
Fibroin proves to be a particularly favorable substrate for the survival and differentiation of ASCs. In vitro studies have documented how ASCs seeded onto porous fibroin scaffolds — appropriately functionalized with insulin, dexamethasone, and other classical adipogenic inducers — undergo efficient differentiation within the first two weeks, with formation of intracellular lipid vacuoles and upregulation of the adipogenic markers PPARγ and FABP4. In vivo, in murine models of subcutaneous adipose defect, ASC-laden scaffolds demonstrate significantly superior volumetric retention compared to autologous fat transplanted using conventional techniques, with denser early vascularization and a reduced fibrotic response.
Clinical applications and the state of translational research
In terms of clinical applications, bioactive fibroin for adipose reconstruction finds its most promising indications across three broad areas: post-mastectomy breast reconstruction, correction of soft tissue defects of post-traumatic or oncological origin, and restoration of facial contours in conditions such as HIV-associated lipoatrophy or Parry-Romberg disease.
Breast reconstruction represents the field in which clinical expectations are highest. The materials currently available — silicone implants, tissue expanders, autologous flaps — all carry significant limitations in terms of complications, the need for long-term revisions, or donor site morbidity. A bioactive fibroin scaffold that guides the neoformation of autogenous adipose tissue could, at least in theory, offer a biological alternative capable of integrating harmoniously with surrounding tissue, adapting to weight fluctuations, and maintaining volume over time without the problems associated with foreign bodies.
Translational research in this field is advanced but not yet fully mature. The majority of available studies remain at the preclinical level, with small animal models — predominantly mice and rats — yielding encouraging results that are not directly transferable to humans for reasons of scale, vascularization, and anatomical complexity.
